(Q34090886)

30 July 2017

title

Comprehensive analysis of citrate effects during plateletpheresis in normal donors (English)

1 reference

30 July 2017

Bolan CD

1

1 reference

30 July 2017

Greer SE

2

1 reference

30 July 2017

Cecco SA

3

1 reference

30 July 2017

Oblitas JM

4

1 reference

30 July 2017

Rehak NN

5

1 reference

30 July 2017

Leitman SF

6

1 reference

30 July 2017

publication date

1 September 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

41

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1165-1171

1 reference

Dosage regimens for citrate anticoagulants.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41091165.X

Frequency of immediate adverse effects associated with apheresis donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41091165.X

Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41091165.X

Changes in protein-bound, complex-bound, and ionized calcium related to parathyroid hormone levels in healthy donors during plateletapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41091165.X

Renal handling of citrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41091165.X

10.1046/J.1537-2995.2001.41091165.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference